Home / IART : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does IART make money? Does IART have pricing power? What's the Earnings Whisper? Will IART profit more as the business scales? What is IART's management track record? Is IART's current price justified?

Integra LifeSciences Holdings Corporation

$15.5 +$3.49 (+29.06%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$15.54

Day Range

$15.33$16.22

Year Range

$8.7$20.49

Market Cap

1.21B

AVG Volume

948.52K

Trailing/Forward PE

-168.11/5.94

PEG ratio

-27.18

Dividend Yield

Next Earnings Date

2026-10-29

Primary Exchange

NASDAQ

Revenue (USD)

IART Revenue (USD) by year
Period	Revenue (USD)
2025	1.64B
2024	1.61B
2023	1.54B
2022	1.56B
2021	1.54B
2020	1.37B
2019	1.52B
2018	1.47B
2017	1.19B
2016	992.07M

Net Income (USD)

IART Net Income (USD) by year
Period	Net Income (USD)
2025	-516.47M
2024	-6.94M
2023	67.74M
2022	180.55M
2021	169.07M
2020	133.89M
2019	50.2M
2018	60.8M
2017	64.74M
2016	72.79M

Operating Income (USD)

IART Operating Income (USD) by year
Period	Operating Income (USD)
2025	68.32M
2024	28.41M
2023	111.53M
2022	238.92M
2021	197.23M
2020	151.37M
2019	93.76M
2018	111M
2017	44.8M
2016	115.36M

EBITDA (USD)

IART EBITDA (USD) by year
Period	EBITDA (USD)
2025	-326.2M
2024	193.29M
2023	257.22M
2022	377.14M
2021	366.28M
2020	281.13M
2019	185.17M
2018	345.34M
2017	267.65M
2016	225.6M

Cash Flows (USD)

IART Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-45.25M
2024	15.01M
2023	73.09M
2022	217.38M
2021	264.4M
2020	159.94M
2019	96.9M
2018	121.94M
2017	71.04M
2016	69.08M

EPS (USD)

IART EPS (USD) by year
Period	EPS (USD)
2025	-6.75
2024	-0.09
2023	0.83
2022	2.16
2021	1.98
2020	1.58
2019	0.58
2018	0.72
2017	0.82
2016	0.94

Expenses (USD)

IART Expenses (USD) by year
Period	Expenses (USD)
2025	894.31M
2024	946.73M
2023	827.7M
2022	764.59M
2021	778.52M
2020	715.8M
2019	903.38M
2018	846.53M
2017	731.05M
2016	561.09M

Cash & Debt (USD)

IART Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	263.74M
2024	273.57M
2023	309.1M
2022	456.66M
2021	513.45M
2020	470.17M
2019	198.91M
2018	138.84M
2017	174.94M
2016	102.06M

Debt ratios

IART Debt ratios by year
Period	Debt ratios
2025	3.53
2024	1.43
2023	1.07
2022	0.97
2021	0.98
2020	1.1
2019	1.24
2018	1.18

Margins

IART Margins by year
Period	Margins
2025	51.69%
2024	54.77%
2023	57.39%
2022	62.29%
2021	61.24%
2020	62.03%
2019	62.79%
2018	61.19%
2017	63.35%
2016	64.81%

Return on Capital

IART Return on Capital by year
Period	Return on Capital
2025	-49.5%
2024	-0.45%
2023	4.27%
2022	10.01%
2021	10.04%
2020	8.84%
2019	3.54%
2018	4.42%
2017	6.73%
2016	8.67%

Shares Outstanding

IART Shares Outstanding by year
Period	Shares Outstanding
2025	76.75M
2024	77.01M
2023	78.33M
2022	83.65M
2021	84.7M
2020	84.34M
2019	85.87M
2018	86.68M
2017	78.39M
2016	74.72M

Book Value Per Share (USD)

IART Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	13.6
2024	20.07
2023	20.27
2022	21.57
2021	19.89
2020	17.96
2019	16.5
2018	15.87
2017	12.28
2016	11.24

Total Assets (USD)

IART Total Assets (USD) by year
Period	Total Assets (USD)
2025	3.6B
2024	4.04B
2023	3.78B
2022	3.89B
2021	3.78B
2020	3.62B
2019	3.3B
2018	3.11B
2017	3.21B
2016	1.81B

Employee Count

IART Employee Count by year
Period	Employee Count
2025	4.43K
2024	4.4K
2023	3.95K
2022	3.72K
2021	3.8K
2020	3.7K
2019	4K
2018	4.5K
2017	4.4K
2016	3.7K

PE Ratio

IART PE Ratio by year
Period	PE Ratio
Nov 24	63.11
Oct 24	62.03
Oct 24	65.04
Oct 24	62.95
Oct 24	55.65
Sep 24	58.5
Sep 24	56.96
Sep 24	57.19
Sep 24	60.56
Aug 24	66.58
Aug 24	68.97
Aug 24	70.57
Aug 24	71.36
Aug 24	78.69
Jul 24	60.73
Jul 24	60.55
Jul 24	57.98
Jul 24	55.72
Jun 24	56.3
Jun 24	57.02
Jun 24	56.51
Jun 24	59.51
May 24	59.7
May 24	54.7
May 24	53.21
May 24	50.21
May 24	33.4
Apr 24	32.77
Apr 24	33.16
Apr 24	37.93
Apr 24	39.31
Mar 24	40.99
Mar 24	39.04
Mar 24	40.12
Mar 24	42.47
Mar 24	41.61
Feb 24	35.34
Feb 24	35.59
Feb 24	33.53
Feb 24	31.74
Jan 24	33.06
Jan 24	33.49
Jan 24	33.93
Jan 24	33.23
Dec 23	34.41
Dec 23	35.23
Dec 23	33.8
Dec 23	32.61
Dec 23	32.41
Nov 23	31.25
Nov 23	30.62
Nov 23	28.57
Nov 23	30.62
Oct 23	27.03
Oct 23	23.4
Oct 23	23.6
Oct 23	23.57
Sep 23	23.56
Sep 23	23.78
Sep 23	24.44
Sep 23	23.91
Sep 23	26.37
Aug 23	25.65
Aug 23	26.13
Aug 23	26.93
Aug 23	27.66
Jul 23	28.06
Jul 23	21.61
Jul 23	20.46
Jul 23	19.16
Jun 23	19.59
Jun 23	18.84
Jun 23	19.74
Jun 23	19.35
Jun 23	18.55
May 23	18.32
May 23	23.72
May 23	23.36
May 23	24.17
Apr 23	26.35
Apr 23	26.97
Apr 23	27.33
Apr 23	26.59
Mar 23	26.6
Mar 23	25.46
Mar 23	24.76
Mar 23	24.5
Mar 23	25.85
Feb 23	26.28
Feb 23	27.62
Feb 23	27.86
Feb 23	28.62
Jan 23	27.95
Jan 23	27.01
Jan 23	27.55
Jan 23	28.18
Dec 22	26.92
Dec 22	27.02
Dec 22	26.61
Dec 22	26.82

Free Cash Flow Yield

IART Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	3.2%
Sep 26	2.97%
Aug 26	2.94%
Aug 26	2.96%
Aug 26	2.7%
Aug 26	2.87%
Jul 26	2.98%
Jul 26	-0.66%
Jul 26	-0.68%
Jul 26	-0.7%
Jul 26	-0.73%
Jun 26	-0.7%
Jun 26	-0.75%
Jun 26	-0.74%
Jun 26	-0.77%
May 26	-0.82%
May 26	-0.87%
May 26	-0.93%
May 26	-0.94%
May 26	-5.38%
Apr 26	-5.58%
Apr 26	-5.29%
Apr 26	-5.96%
Apr 26	-6.19%
Mar 26	-6.41%
Mar 26	-6.6%
Mar 26	-6.38%
Mar 26	-6.06%
Feb 26	-5.18%
Feb 26	-1.54%
Feb 26	-1.67%
Feb 26	-1.67%
Jan 26	-1.69%
Jan 26	-1.58%
Jan 26	-1.52%
Jan 26	-1.39%
Jan 26	-1.57%
Dec 25	-1.49%
Dec 25	-1.49%
Dec 25	-1.4%
Dec 25	-1.42%
Nov 25	-1.44%
Nov 25	-1.57%
Nov 25	-1.6%
Nov 25	-1.57%
Oct 25	-1.57%
Oct 25	-3.84%
Oct 25	-4.11%
Oct 25	-4.64%
Oct 25	-4.19%
Sep 25	-4.69%
Sep 25	-4.39%
Sep 25	-4.11%
Sep 25	-3.88%
Aug 25	-4.1%
Aug 25	-4.17%
Aug 25	-4.37%
Aug 25	-4.78%
Aug 25	-5.03%
Jul 25	-2.54%
Jul 25	-2.99%
Jul 25	-2.64%
Jul 25	-2.47%
Jun 25	-2.71%
Jun 25	-2.87%
Jun 25	-2.74%
Jun 25	-2.46%
May 25	-2.63%
May 25	-2.71%
May 25	-2.45%
May 25	-2.72%
May 25	1.16%
Apr 25	1.16%
Apr 25	1.23%
Apr 25	1.15%
Apr 25	1%
Mar 25	0.9%
Mar 25	0.87%
Mar 25	0.87%
Mar 25	0.85%
Feb 25	0.84%
Feb 25	2.35%
Feb 25	2.06%
Feb 25	1.97%
Jan 25	1.91%
Jan 25	1.91%
Jan 25	2.06%
Jan 25	2.28%
Jan 25	2.15%
Dec 24	2.23%
Dec 24	2.28%
Dec 24	2.07%
Dec 24	2.06%
Nov 24	2.02%
Nov 24	2.11%
Nov 24	2.17%
Nov 24	2.01%
Nov 24	3.95%
Oct 24	4.01%
Oct 24	3.83%

Price to Sales

IART Price to Sales by year
Period	Price to Sales
Sep 26	0.74
Sep 26	0.79
Aug 26	0.8
Aug 26	0.79
Aug 26	0.87
Aug 26	0.82
Jul 26	0.79
Jul 26	0.93
Jul 26	0.9
Jul 26	0.88
Jul 26	0.84
Jun 26	0.88
Jun 26	0.82
Jun 26	0.83
Jun 26	0.8
May 26	0.75
May 26	0.71
May 26	0.66
May 26	0.65
May 26	0.51
Apr 26	0.5
Apr 26	0.52
Apr 26	0.46
Apr 26	0.45
Mar 26	0.43
Mar 26	0.42
Mar 26	0.43
Mar 26	0.46
Feb 26	0.53
Feb 26	0.57
Feb 26	0.53
Feb 26	0.53
Jan 26	0.52
Jan 26	0.56
Jan 26	0.58
Jan 26	0.63
Jan 26	0.56
Dec 25	0.59
Dec 25	0.59
Dec 25	0.63
Dec 25	0.62
Nov 25	0.61
Nov 25	0.56
Nov 25	0.55
Nov 25	0.56
Oct 25	0.56
Oct 25	0.76
Oct 25	0.71
Oct 25	0.63
Oct 25	0.7
Sep 25	0.62
Sep 25	0.67
Sep 25	0.71
Sep 25	0.75
Aug 25	0.71
Aug 25	0.7
Aug 25	0.67
Aug 25	0.61
Aug 25	0.58
Jul 25	0.62
Jul 25	0.52
Jul 25	0.59
Jul 25	0.64
Jun 25	0.58
Jun 25	0.55
Jun 25	0.57
Jun 25	0.64
May 25	0.6
May 25	0.58
May 25	0.64
May 25	0.58
May 25	0.81
Apr 25	0.8
Apr 25	0.76
Apr 25	0.81
Apr 25	0.94
Mar 25	1.04
Mar 25	1.08
Mar 25	1.07
Mar 25	1.1
Feb 25	1.11
Feb 25	1.03
Feb 25	1.18
Feb 25	1.23
Jan 25	1.28
Jan 25	1.27
Jan 25	1.18
Jan 25	1.07
Jan 25	1.13
Dec 24	1.09
Dec 24	1.06
Dec 24	1.17
Dec 24	1.18
Nov 24	1.2
Nov 24	1.15
Nov 24	1.12
Nov 24	1.21
Nov 24	0.95
Oct 24	0.94
Oct 24	0.98

EV/EBITDA

IART EV/EBITDA by year
Period	EV/EBITDA
Sep 26	11.97
Sep 26	12.35
Aug 26	12.4
Aug 26	12.36
Aug 26	12.86
Aug 26	12.52
Jul 26	12.33
Jul 25	15.24
Jul 25	14.4
Jul 25	15.02
Jul 25	15.4
Jun 25	14.89
Jun 25	14.6
Jun 25	14.84
Jun 25	15.43
May 25	15.05
May 25	14.9
May 25	15.44
May 25	14.88
May 25	15.57
Apr 25	15.55
Apr 25	15.16
Apr 25	15.62
Apr 25	16.65
Mar 25	17.49
Mar 25	17.81
Mar 25	17.76
Mar 25	18.02
Feb 25	18.1
Feb 25	17.72
Feb 25	18.96
Feb 25	19.38
Jan 25	19.74
Jan 25	19.72
Jan 25	18.93
Jan 25	18
Jan 25	18.55
Dec 24	18.21
Dec 24	17.99
Dec 24	18.9
Dec 24	18.93
Nov 24	19.12
Nov 24	18.72
Nov 24	18.43
Nov 24	19.21
Nov 24	14.91
Oct 24	14.79
Oct 24	15.12
Oct 24	14.89
Oct 24	14.08
Sep 24	14.4
Sep 24	14.23
Sep 24	14.25
Sep 24	14.62
Aug 24	15.29
Aug 24	15.55
Aug 24	15.73
Aug 24	15.81
Aug 24	16.62
Jul 24	17.23
Jul 24	17.19
Jul 24	16.73
Jul 24	16.32
Jun 24	16.42
Jun 24	16.55
Jun 24	16.46
Jun 24	17.01
May 24	17.04
May 24	16.13
May 24	15.86
May 24	15.32
May 24	14.13
Apr 24	13.97
Apr 24	14.07
Apr 24	15.32
Apr 24	15.69
Mar 24	16.13
Mar 24	15.62
Mar 24	15.9
Mar 24	16.52
Mar 24	16.3
Feb 24	17.31
Feb 24	17.39
Feb 24	16.67
Feb 24	16.04
Jan 24	16.51
Jan 24	16.66
Jan 24	16.81
Jan 24	16.57
Dec 23	16.98
Dec 23	17.27
Dec 23	16.76
Dec 23	16.35
Dec 23	16.28
Nov 23	15.87
Nov 23	15.65
Nov 23	14.93
Nov 23	15.65
Oct 23	14.39
Oct 23	13.3

Price/Operating Cashflow

IART Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	14.2
Sep 26	15.32
Aug 26	15.47
Aug 26	15.34
Aug 26	16.8
Aug 26	15.8
Jul 26	15.25
Jul 26	21.32
Jul 26	20.73
Jul 26	20.24
Jul 26	19.44
Jun 26	20.21
Jun 26	18.94
Jun 26	19.14
Jun 26	18.3
May 26	17.28
May 26	16.26
May 26	15.19
May 26	14.99
May 26	16.68
Apr 26	16.1
Apr 26	16.97
Apr 26	15.08
Apr 26	14.52
Mar 26	14.01
Mar 26	13.62
Mar 26	14.08
Mar 26	14.82
Feb 26	17.34
Feb 26	10.49
Feb 26	9.73
Feb 26	9.68
Jan 26	9.57
Jan 26	10.23
Jan 26	10.67
Jan 26	11.67
Jan 26	10.32
Dec 25	10.85
Dec 25	10.87
Dec 25	11.53
Dec 25	11.38
Nov 25	11.28
Nov 25	10.35
Nov 25	10.1
Nov 25	10.35
Oct 25	10.32
Oct 25	17.39
Oct 25	16.27
Oct 25	14.39
Oct 25	15.96
Sep 25	14.24
Sep 25	15.24
Sep 25	16.24
Sep 25	17.25
Aug 25	16.32
Aug 25	16.03
Aug 25	15.31
Aug 25	13.98
Aug 25	13.28
Jul 25	9.79
Jul 25	8.31
Jul 25	9.4
Jul 25	10.08
Jun 25	9.18
Jun 25	8.66
Jun 25	9.08
Jun 25	10.13
May 25	9.46
May 25	9.19
May 25	10.14
May 25	9.15
May 25	10.03
Apr 25	10.01
Apr 25	9.42
Apr 25	10.11
Apr 25	11.65
Mar 25	12.91
Mar 25	13.39
Mar 25	13.3
Mar 25	13.69
Feb 25	13.81
Feb 25	11.76
Feb 25	13.45
Feb 25	14.03
Jan 25	14.52
Jan 25	14.49
Jan 25	13.41
Jan 25	12.14
Jan 25	12.89
Dec 24	12.42
Dec 24	12.13
Dec 24	13.37
Dec 24	13.41
Nov 24	13.68
Nov 24	13.12
Nov 24	12.73
Nov 24	13.79
Nov 24	10.53
Oct 24	10.35
Oct 24	10.86

Price to Book

IART Price to Book by year
Period	Price to Book
Sep 26	1.15
Sep 26	1.24
Aug 26	1.26
Aug 26	1.25
Aug 26	1.36
Aug 26	1.28
Jul 26	1.24
Jul 26	1.46
Jul 26	1.42
Jul 26	1.39
Jul 26	1.33
Jun 26	1.38
Jun 26	1.3
Jun 26	1.31
Jun 26	1.25
May 26	1.18
May 26	1.11
May 26	1.04
May 26	1.03
May 26	0.81
Apr 26	0.78
Apr 26	0.82
Apr 26	0.73
Apr 26	0.7
Mar 26	0.68
Mar 26	0.66
Mar 26	0.68
Mar 26	0.72
Feb 26	0.84
Feb 26	0.9
Feb 26	0.84
Feb 26	0.83
Jan 26	0.82
Jan 26	0.88
Jan 26	0.92
Jan 26	1
Jan 26	0.89
Dec 25	0.93
Dec 25	0.94
Dec 25	0.99
Dec 25	0.98
Nov 25	0.97
Nov 25	0.89
Nov 25	0.87
Nov 25	0.89
Oct 25	0.89
Oct 25	1.19
Oct 25	1.11
Oct 25	0.98
Oct 25	1.09
Sep 25	0.97
Sep 25	1.04
Sep 25	1.11
Sep 25	1.18
Aug 25	1.11
Aug 25	1.09
Aug 25	1.04
Aug 25	0.95
Aug 25	0.91
Jul 25	0.66
Jul 25	0.56
Jul 25	0.63
Jul 25	0.68
Jun 25	0.62
Jun 25	0.58
Jun 25	0.61
Jun 25	0.68
May 25	0.64
May 25	0.62
May 25	0.68
May 25	0.61
May 25	0.84
Apr 25	0.84
Apr 25	0.79
Apr 25	0.85
Apr 25	0.98
Mar 25	1.08
Mar 25	1.12
Mar 25	1.11
Mar 25	1.15
Feb 25	1.16
Feb 25	1.06
Feb 25	1.21
Feb 25	1.27
Jan 25	1.31
Jan 25	1.31
Jan 25	1.21
Jan 25	1.1
Jan 25	1.16
Dec 24	1.12
Dec 24	1.1
Dec 24	1.21
Dec 24	1.21
Nov 24	1.23
Nov 24	1.18
Nov 24	1.15
Nov 24	1.25
Nov 24	0.97
Oct 24	0.96
Oct 24	1

No video analysis for this stock yet. Request one from our team.

News: IART

globenewswire.com · 4 Sep 2026

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Stuart Essig, chairman and chief executive officer, will present at the 2026 Morgan Stanley Healthcare Conference on Tuesday, September 15, 2026, at 4:05 p.m. ET.

seekingalpha.com · 2 Sep 2026

Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis

Integra LifeSciences Holdings is a turnaround story, maintaining a BUY rating after a strong 2Q26 earnings beat and margin expansion. IART's specialty surgery segment led revenue, while tissue reconstruction saw declines offset by a successful PriMatrix relaunch and upcoming SurgiMend reintroduction. Management targets leverage reduction to 2.5–3.5x by end-2026, prioritizing debt repayment as operating cash flow improves.

zacks.com · 28 Aug 2026

Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?

Integra (IART) reported earnings 30 days ago. What's next for the stock?

zacks.com · 27 Aug 2026

Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com · 20 Aug 2026

Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?

Integra's SurgiMend relaunch could support a broader 2027 recovery, but customer recapture and FDA approval remain key to the upside.

zacks.com · 19 Aug 2026

Is IART Still Attractive as Its Low Valuation Meets Execution Risks?

Integra's steep valuation discount meets margin gains and cost savings, but modest growth, leverage and unresolved FDA risks keep execution in focus.

zacks.com · 5 Aug 2026

Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock